CardioMech confirmed the completion of the first procedure with its transcatheter mitral valve repair (TMVR) technology.
At the Sanger Heart & Vascular Institute in North Carolina, a multidisciplinary heart team evaluated a patient diagnosed with severe symptomatic degenerative mitral regurgitation (DMR). They offered the patient a choice: open-heart surgery (the standard of care) or the new, investigational CardioMech MVRS, according to a report out yesterday from Atrium Health.
